Several clinical trials have investigated the use of methylphenidate for managing CRF. While some studies report positive outcomes, others have shown mixed results. A systematic review and meta-analysis are often recommended to evaluate the overall efficacy and safety of the drug in this specific context. However, the general consensus is that methylphenidate can be beneficial for some patients, particularly when other interventions have failed.
